Perbedaan Cipta Sarana Medika Tbk. dan Penta Valent Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Penta Valent Tbk. diperdagangkan di Rp310 (kapitalisasi pasar 557,94 M, volume 24 jam 519,4 rb). Perbedaan utamanya: Penta Valent Tbk. jauh lebih besar — sekitar 3,5× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 519,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | PEVE | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 557,94 M |
Volume | 8,21 jt | 519,4 rb |
Lot | 82,15 rb | 5,19 rb |
Perputaran | 515,2 jt | 162,65 jt |
Harga Rata-rata | 62,72 | 313,16 |
Nilai Transaksi | 515,2 jt | 162,65 jt |
Harga Ekuilibrium Indikatif | 63 | 310 |
Volume Ekuilibrium Indikatif | 1,33 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Selengkapnya di halaman PEVE →